Title: An S, et al. Small-molecule PROTACs: An emerging and promising approach for the development of targeted therapy drugs. EBioMedicine. 2018 Oct;36:553-562
123-91-1
31290-76-3
109-59-1
130812-47-4
53609-62-4
63663-09-2
89711-08-0 | N-Boc-2-aminoacetaldehyde | AA0035JZ | MFCD01321273
871700-17-3 | Trametinib | AA0035ML | MFCD17215075
5824-40-8 | Tritylamine | AA0035PF | MFCD00008047
1055331-73-1 | 2-Bromo-5-fluoro-3-nitrobenzoic acid | AA0035SX | MFCD12173018
60656-87-3 | Benzyloxyacetaldehyde | AA0035VU | MFCD00191779
994-89-8 | Tributylstannylacetylene | AA0035Z3 | MFCD00009420
851377-62-3 | Butan-2-ylhydrazine hydrochloride | AA00362L | MFCD28118261
134523-03-8 | Atorvastatin Hemicalcium | AA003660 | MFCD09752074
874219-28-0 | 3-(Diethylcarbamoyl)-4-fluorophenylboronic acid | AA00368Z | MFCD08235047
871115-32-1 | tert-Butyl 4-amino-4-(aminomethyl)piperidine-1-carboxylate | AA0036C3 | MFCD08234568